Trials / Conditions / Bullous Pemphigoid (BP)
Bullous Pemphigoid (BP)
6 registered clinical trials studyying Bullous Pemphigoid (BP) — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid NCT07210554 | Chengdu Kangnuoxing Biopharma,Inc. | Phase 3 |
| Enrolling By Invitation | Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) NCT06723106 | Chugai Pharmaceutical | Phase 1 |
| Recruiting | Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) NCT06371417 | Chugai Pharmaceutical | Phase 1 |
| Completed | Prevalence of Sleep Disturbances in Bullous Pemphigoid Patients. NCT07188402 | University Hospital, Rouen | — |
| Completed | rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects NCT04035733 | AKARI Therapeutics | Phase 2 |
| Completed | Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated Disor NCT02502903 | Bioverativ, a Sanofi company | Phase 1 |